// App-Quantinova.ai

BSH2020‐PO‐074 : An evaluation of double or triple positivity in JAK2 positive essential thrombocythaemia and primary myelofibrosis

Researchers

Presenter

  • P. Scott

Principal Investigators

  • M. Tahhan

  • B. Milner

  • M. Khan

Medical Centers

  • Laboratory Genetics and Molecular Pathology, North East Genetics Services

  • Haematology, Aberdeen Royal Infirmary, Aberdeen

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Essential thrombocythemia

  • Polycythaemia vera

  • Myelofibrosis

Biomarkers

  • MPL proto-oncogene, thrombopoietin receptor

  • Calreticulin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved